Mixed dyslipidemias in primary care patients in France

References

• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110222723915249516
   PubMed Web of Science ®Google Scholar
• GrahamIAtarDBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)Eur Heart J200728192375241417726041
   PubMed Web of Science ®Google Scholar
• De BackerGAmbrosioniEBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J200324171601161012964575
   PubMed Web of Science ®Google Scholar
• KannelWBHigh-density lipoproteins: epidemiologic profile and risks of coronary artery diseaseAm J Cardiol19835249B12B
   PubMed Web of Science ®Google Scholar
• GordonTCastelliWPHjortlandMCKannelWBDawberTRHigh density lipoprotein as a protective factor against coronary heart disease. The Framingham StudyAm J Med1977625707714193398
   PubMed Web of Science ®Google Scholar
• GoldbourtUMedalieJHHigh density lipoprotein cholesterol and incidence of coronary heart disease – the Israeli Ischemic Heart Disease StudyAm J Epidemiol19791093296308222135
   PubMed Web of Science ®Google Scholar
• AssmannGSchulteHRelation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster studyAm J Cardiol19927077337371519522
   PubMed Web of Science ®Google Scholar
• SacksFMTonkinAMShepherdJEffect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling ProjectCirculation2000102161893190011034935
   PubMed Web of Science ®Google Scholar
• BarterPGottoAMLaRosaJCHDL cholesterol, very low levels of LDL cholesterol, and cardiovascular eventsN Engl J Med2007357131301131017898099
   PubMed Web of Science ®Google Scholar
• MorrisonAHokansonJEThe independent relationship between triglycerides and coronary heart diseaseVasc Health Risk Manag200951899519436658
   PubMedGoogle Scholar
• BirjmohunRSHuttenBAKasteleinJJStroesESEfficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trialsJ Am Coll Cardiol200545218519715653014
   PubMed Web of Science ®Google Scholar
• EdwardsJEMooreRAStatins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trialsBMC Fam Pract200341814969594
   PubMedGoogle Scholar
• LawMRWaldNJRudnickaARQuantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ20033267404142312829554
   PubMed Web of Science ®Google Scholar
• DavidsonMHMcKenneyJMShearCLRevkinJHEfficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levelsJ Am Coll Cardiol20064891774178117084249
   PubMed Web of Science ®Google Scholar
• OramJFTangier disease and ABCA1Biochim Biophys Acta200015291–332133011111099
   PubMed Web of Science ®Google Scholar
• BenlianPEtienneJde GennesJLHomozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombinationJ Lipid Res19953623563667751824
   PubMed Web of Science ®Google Scholar
• BenlianPDe GennesJLFoubertLZhangHGagneSEHaydenMPremature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase geneN Engl J Med1996335128488548778602
   PubMed Web of Science ®Google Scholar
• HokansonJEFunctional variants in the lipoprotein lipase gene and risk cardiovascular diseaseCurr Opin Lipidol199910539339910554701
   PubMed Web of Science ®Google Scholar
• WittrupHHTybjaerg-HansenANordestgaardBGLipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysisCirculation199999222901290710359734
   PubMed Web of Science ®Google Scholar
• ThornJANeedhamEWMattuRKStocksJGaltonDJThe Ser447- Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twinsJ Lipid Res19983924374419508003
   PubMed Web of Science ®Google Scholar
• GagneSELarsonMGPimstoneSNA common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring StudyClin Genet199955645045410450862
   PubMed Web of Science ®Google Scholar
• Van GanseESouchetTLaforestLIneffectiveness of lipid-lowering therapy in primary careBr J Clin Pharmacol200559445646315801941
   PubMed Web of Science ®Google Scholar
• FerrieresJGousseETFabryCHermansMPAssessment of lipid-lowering treatment in France–the CEPHEUS studyArch Cardiovasc Dis2008101955756319041840
   PubMed Web of Science ®Google Scholar
• Van GanseELaforestLAlemaoEDaviesGGutkinSYinDLipid- modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) studyCurr Med Res Opin20052191389139916197657
   PubMed Web of Science ®Google Scholar
• DupuyAMCarriereIScaliJLipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agentsClimacteric2008111748318202967
   PubMed Web of Science ®Google Scholar
• DallongevilleJBringerJBruckertEAbdominal obesity is associated with ineffective control of cardiovascular risk factors in primary care in FranceDiabetes Metab2008346 Pt 160661119019717
   PubMed Web of Science ®Google Scholar
• KolovouGDAnagnostopoulouKKDamaskosDSGender differences in the lipid profile of dyslipidemic subjectsEur J Intern Med200920214515119327602
   PubMed Web of Science ®Google Scholar
• LozanoJVPallaresVCea-CalvoLSerum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS studyCurr Med Res Opin200824365967018218194
   PubMed Web of Science ®Google Scholar
• Van GanseELaforestLBurkeTPhatakHSouchetTMixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational studyClin Ther20072981671168117919548
   PubMed Web of Science ®Google Scholar
• De BackerGAmbrosioniEBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts)Eur J Cardiovasc Prev Rehabil2003104S11014555889
   PubMedGoogle Scholar
• BruckertEBaccara-DinetMMcCoyFChapmanJHigh prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patientsCurr Med Res Opin200521121927193416368042
   PubMed Web of Science ®Google Scholar
• Agence Française de Sécurité Sanitaire des Produits de SantéPrise en charge thérapeutique du patient dyslipidémiqueSaint-Denis Cedex, FranceAFSSPS2005 French
   Google Scholar
• LaforestLMoulinPSouchetTCorrelates of LDL-cholesterol goal attainment in patients under lipid lowering therapyAtherosclerosis2008199236837718191135
   PubMed Web of Science ®Google Scholar
• Van GanseESouchetTLaforestLLong-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational studyAtherosclerosis20061851586416038912
   PubMed Web of Science ®Google Scholar
• ChassanyOLe-JeunnePDuracinskyMSchwalmMSMathieuMDiscrepancies between patient-reported outcomes and clinician-reported outcomes in chronic venous disease, irritable bowel syndrome, and peripheral arterial occlusive diseaseValue Health200691394616441523
   PubMed Web of Science ®Google Scholar
• AmouyelPLamarqueHGayetJLTreatment with statins in general medicine: dosage and effectiveness. Results of the observational study STATIMEDArch Mal Coeur Vaiss2005981212061211 French16435599
   PubMedGoogle Scholar
• GraesslinOHoffetMBarjotPPreliminary results from the OPNI observatory: long-term follow-up of a cohort of women using the progestagen contraceptive implant ImplanonGynecol Obstet Fertil2005335315321 French15878686
   PubMedGoogle Scholar
• BoueeSCharlemagneAFagnaniFChanges in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapyJoint Bone Spine200471321422015182793
   PubMed Web of Science ®Google Scholar
• WilsonPWD’AgostinoRBLevyDBelangerAMSilbershatzHKannelWBPrediction of coronary heart disease using risk factor categoriesCirculation19989718183718479603539
   PubMed Web of Science ®Google Scholar
• PutzerGRoetzheimRRamirezAMSneedKBrownleeHJJrCampbellRJCompliance with recommendations for lipid management among patients with type 2 diabetes in an academic family practiceJ Am Board Fam Pract200417210110715082668
   PubMedGoogle Scholar
• ParrisESLawrenceDBMohnLALongLBAdherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemiaDiabetes Care200528359559915735194
   PubMed Web of Science ®Google Scholar
• SchultzJSO’DonnellJCMcDonoughKLSasaneRMeyerJDeterminants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care populationAm J Manag Care200511530631215898219
   PubMed Web of Science ®Google Scholar